22nd Century Group, Inc.
Most Recent
Performances of ETFs Investing in Cannabis Stocks in Week 48
Cannabis industry ETFs are designed for those who can’t hold many stocks but are interested in diversifying within the cannabis sector.
What to Expect from Curaleaf’s Q3 Earnings
For the third quarter of 2018, Wall Street analysts estimate Curaleaf Holdings to report revenues of ~28.1 million Canadian dollars.
Why Was MedMen’s Trading Halted?
MedMen stock has fallen ~29.6% in November. The stock fell 26.3% in the last five trading sessions to close at $3.52 on November 20.
Analyzing 22nd Century Group’s Year-to-Date Performance
Analysts expect 22nd Century Group to report revenue of $23.3 million in 2018, a 40.3% rise compared to $16.6 million in 2017.
